Cargando…
Differential Glycosylation Expression in Injured Rat Spinal Cord Treated with Immunosuppressive Drug Cyclosporin-A
[Image: see text] Glycosylation is ubiquitous throughout the central nervous system and altered following spinal cord injury (SCI). The glial scar that forms following SCI is composed of several chondroitin sulfate proteoglycans, which inhibit axonal regrowth. Cyclosporin-A (CsA), an immunosuppressi...
Autores principales: | Kilcoyne, Michelle, Patil, Vaibhav, O’Grady, Claire, Bradley, Ciara, McMahon, Siobhan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407839/ https://www.ncbi.nlm.nih.gov/pubmed/30868109 http://dx.doi.org/10.1021/acsomega.8b02524 |
Ejemplares similares
-
An insight into new glycotherapeutics in glial inflammation: Understanding the role of glycosylation in mitochondrial function and acute to the chronic phases of inflammation
por: Patil, Vaibhav, et al.
Publicado: (2022) -
Distinct Glycosylation
Responses to Spinal Cord Injury
in Regenerative and Nonregenerative Models
por: Ronan, Rachel, et al.
Publicado: (2022) -
Lentiviral Vectors Delivered with Biomaterials as Therapeutics for Spinal Cord Injury
por: Shortiss, Ciara, et al.
Publicado: (2021) -
A robust platform for high-throughput screening of therapeutic strategies for acute and chronic spinal cord injury
por: Patil, Vaibhav, et al.
Publicado: (2021) -
Plasticity of the Injured Spinal Cord
por: Guérout, Nicolas
Publicado: (2021)